Amendment No. 1 to Amended and Restated Right of First Refusal and Co-Sale Agreement by and among Symbion, Inc. and Investors

Summary

This amendment, dated August 11, 1999, is between Symbion, Inc. and its investors. It updates the existing Right of First Refusal and Co-Sale Agreement to allow Richland Ventures III, L.P. and certain new share purchasers to become parties to the agreement if they acquire specified shares and sign the agreement. These new parties will have the same rights and obligations as current investors, subject to the terms of the agreement. The amendment also gives the company discretion to designate the status of new share purchasers under the agreement.

EX-4.8 12 g76584exv4w8.txt AMENDMENT NO. 1 TO RESTATED RIGHT OF FIRST REFUSAL EXHIBIT 4.8 AMENDMENT NO. 1 TO AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT THIS AMENDMENT NO. 1 TO AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT ("Amendment") is made and entered into as of August 11, 1999, by and among SYMBION, INC., a Tennessee corporation formerly named "UniPhy Healthcare, Inc." (the "Company"), and those Persons identified on Exhibit A attached hereto (collectively, the "Investors" and each individually an "Investor"). R E C I T A L S: WHEREAS, the Company and the Investors are parties to that certain Amended and Restated Right of First Refusal and Co-Sale Agreement, dated as of June 25, 1999 (the "Right of First Refusal and Co-Sale Agreement"); WHEREAS, the Company and certain of the Investors are parties to that certain Securities Purchase Agreement, dated as of July 6, 1999 (the "Purchase Agreement"); WHEREAS, Section 1(B) of the Purchase Agreement grants an option (the "Option") of limited duration to Richland Ventures III, L.P. ("RVIII") to purchase up to 3,191,489 shares (the "Option Shares") of the common stock, no par value (the "Common Stock"), of the Company, at a purchase price of $1.88 per share; WHEREAS, in the event that RVIII purchases the Option Shares, the Company and the Investors desire that RVIII obtain the rights and obligations of an "Investor" and an "ARC Key Shareholder" under the Right of First Refusal and Co-Sale Agreement; WHEREAS, the Company may, pursuant to Section 1(C) of the Purchase Agreement, issue and sell up to 5,319,149 shares (the "Reserve Shares") of Common Stock (including the Option Shares) to any person or entity (each, a "Reserve Share Purchaser"); WHEREAS, in the event that a Reserve Share Purchaser purchases Reserve Shares, the Company and the Investors may desire that such Reserve Share Purchaser have the rights and obligations of an "Investor," a "UniPhy Preferred Shareholder," a "UniPhy Founder" or an "ARC Key Shareholder" under the Right of First Refusal and Co-Sale Agreement; WHEREAS, the Company and the Investors desire to amend the Right of First Refusal and Co-Sale Agreement as set forth in this Amendment, pursuant to Section 6(c) of the Right of First Refusal and Co-Sale Agreement; and WHEREAS, capitalized terms used herein without definition shall have the same meanings ascribed to such terms in the Right of First Refusal and Co-Sale Agreement. NOW, THEREFORE, in consideration of the foregoing and the respective covenants and agreements contained herein, the sufficiency of which is hereby acknowledged, the parties hereby agree and consent to the following: A G R E E M E N T: 1. RVIII Amendment. The Right of First Refusal and Co-Sale Agreement is hereby amended by adding and appending the following as Section 7 of the Right of First Refusal and Co-Sale Agreement: 7. Addition of RVIII as a Party. Notwithstanding the provisions of Section 6(c) or any other Section hereof, upon the occurrence of: (i) the exercise by Richland Ventures III, L.P. ("RVIII") of the option (the "Option") to purchase up to 3,191,489 shares (the "Option Shares") of Common Stock at a purchase price of $1.88 per share which was granted to RVIII in Section 1(B) of that certain Securities Purchase Agreement, dated as of July 6, 1999 (the "Purchase Agreement"), among the Company and certain purchasers identified in such agreement, and the purchase of Option Shares by RVIII, and (ii) the execution and delivery to the Company by RVIII of a counterpart of this Amended and Restated Right of First Refusal and Co-Sale Agreement (as then amended), adopting and accepting the terms hereof, and (iii) acceptance and countersignature of such counterpart by the Company: (a) RVIII shall be a party to this Amended and Restated Right of First Refusal and Co-Sale Agreement; and (b) Exhibit A attached to this Amended and Restated Right of First Refusal and Co-Sale Agreement shall be amended to add RVIII as a person identified thereon, and RVIII shall be, and shall be included within the definition of, an "Investor" for purposes of this Amended and Restated Right of First Refusal and Co-Sale Agreement; and (c) RVIII shall be, and shall be included within the definition of, an "ARC Key Shareholder," for purposes of this Amended and Restated Right of First Refusal and Co-Sale Agreement; and (d) RVIII shall have, and be entitled and subject to, all of the rights, benefits, duties and obligations of an "Investor" and an "ARC Key Shareholder" under this Amended and Restated Right of First Refusal and Co-Sale Agreement, subject to the terms hereof. 2. Reserve Share Purchasers Amendment. The Investors' Rights Agreement is hereby further amended by adding and appending the following as Section 8 of the Investors' Rights Agreement: 8. Addition of Reserve Share Purchasers as Parties. (a) Reserve Share Purchasers. The parties hereto acknowledge and agree that, pursuant to Section 1(C) of the Purchase Agreement, the Company may issue, offer and sell up to 5,319,149 shares (the "Reserve Shares") of Common Stock (including the 3,191,489 Option Shares) to any person or entity (each, a "Reserve Share Purchaser"). Notwithstanding the provisions of Section 6(c) or any other Section hereof, upon the occurrence of: (1) the purchase from the Company by a 2 Reserve Share Purchaser of Reserve Shares (but not including the purchase of Option Shares by RVIII, which is addressed in and governed by Section 7 above), and (2) the execution and delivery to the Company by such Reserve Share Purchaser of a counterpart of this Amended and Restated Right of First Refusal and Co-Sale Agreement (as then amended), adopting and accepting the terms hereof, and (3) acceptance and countersignature of such counterpart by the Company: (i) such Reserve Share Purchaser shall be a party to this Amended and Restated Right of First Refusal and Co-Sale Agreement; and (ii) Exhibit A attached to this Amended and Restated Right of First Refusal and Co-Sale Agreement shall be amended to add such Reserve Share Purchaser as a person identified thereon, and such Reserve Share Purchaser shall be, and shall be included within the definition of, an "Investor" for purposes of this Amended and Restated Right of First Refusal and Co-Sale Agreement; and (iii) subject to Section 8(b) below, such Reserve Share Purchaser shall be, and shall be included within the definition of, either of a "UniPhy Preferred Shareholder," a "UniPhy Founder" or an "ARC Key Shareholder" (as designated by the Company pursuant to Section 8(b) below), for purposes of this Amended and Restated Right of First Refusal and Co-Sale Agreement; and (iv) subject to Section 8(b) below, such Reserve Share Purchaser shall have, and shall be entitled and subject to, all of the rights, benefits, duties and obligations of an "Investor" and a "UniPhy Preferred Shareholder," a "UniPhy Founder" or an "ARC Key Shareholder" (as designated by the Company pursuant to Section 8(b) below) under this Amended and Restated Right of First Refusal and Co-Sale Agreement, subject to the terms hereof. (b) Designation as UniPhy Preferred Shareholder, UniPhy Founder or ARC Key Shareholder. The Company shall have the right, power and authority, to determine, in its discretion, in negotiation or agreement with one or more Reserve Share Purchasers or otherwise, whether or not a particular Reserve Share Purchaser shall (in addition to becoming a party hereto and an "Investor" hereunder) be identified and/or designated as a "UniPhy Preferred Shareholder," a "UniPhy Founder" or an "ARC Key Shareholder" for purposes of this Amended and Restated Right of First Refusal and Co-Sale Agreement, and thereby have, and be entitled and subject to, all of the rights, benefits, duties and obligations of such designation or identification under this Amended and Restated Right of First Refusal and Co-Sale Agreement, pursuant to Sub-sections 8(a)(iii) and (iv) above. 3. Requisite Approval. Upon execution and delivery of this Amendment by the Company and Investors representing the requisite percentage of the shares of Common Stock set forth in Section 6(c) of the Right of First Refusal and Co-Sale Agreement, this Amendment shall constitute and be deemed to be an amendment to and part of the Right of First Refusal and Co-Sale Agreement. 3 4. No Other Changes. Except as expressly set forth or contemplated in this Amendment, the terms and conditions of the Right of First Refusal and Co-Sale Agreement shall remain in place and shall not be altered, amended or changed in any manner whatsoever, except by any further amendment to the Right of First Refusal and Co-Sale Agreement made in accordance with the terms of the Right of First Refusal and Co-Sale Agreement, as hereby amended. 5. Counterparts. This Amendment may be executed in any number of counterparts and by the different parties hereto on separate counterparts, each of which when executed and delivered shall be deemed an original effective for binding the parties hereto, but all of which shall together constitute one and the same instrument. 4 IN WITNESS WHEREOF, the parties hereto have executed this Amendment to Amended and Restated Right of First Refusal and Co-Sale Agreement, and hereby consent to the amendment and modification of the Right of First Refusal and Co-Sale Agreement provided herein, as of the date first above written. THE COMPANY: SYMBION, INC. By: /s/ Richard E. Francis, Jr. ----------------------------------------- Name: Richard E. Francis, Jr. Title: President and Chief Executive Officer INVESTORS: UNIPHY PREFERRED SHAREHOLDERS: ABS CAPITAL PARTNERS, L.P. /s/ ABS Partners, L.P. - -------------------------------------------- By: /s/ Frederick L. Bryant ---------------------------------------- Name: Frederick L. Bryant -------------------------------------- Title: General Partner ------------------------------------- /s/ Clifford G. Adlerz - -------------------------------------------- Clifford G. Adlerz /s/ Randy W. Cook - -------------------------------------------- Randy W. Cook /s/ Paul Davis - -------------------------------------------- Paul Davis /s/ Richard E. Francis, Jr. - ----------------------------------------------------- Richard E. Francis, Jr. /s/ R. Dale Kennedy - -------------------------------------------- R. Dale Kennedy 5 - -------------------------------------------- Tod Lambert MARTIN INVESTMENT PARTNERSHIP II /s/ Charles N. Martin, Jr. - ------------------------------------------- Name: -------------------------------------- Title: ------------------------------------ /s/ Kenneth C. Mitchell - ------------------------------------------- Kenneth C. Mitchell PACIFIC VENTURE GROUP, L.P. By: PVG Equity Partner, L.L.C., its General Partner /s/ Eve M. Kurtin - ------------------------------------------- By: Eve M. Kurtin Title: Member PVG ASSOCIATES, L.P. By: PVG Equity Partner, L.L.C., its General Partner /s/ Eve M. Kurtin - ------------------------------------------- By: Eve M. Kurtin Title: Member /s/ Patrick R. Rooney - ------------------------------------------- Patrick R. Rooney /s/ Teresa F. Sparks - ------------------------------------------- Teresa F. Sparks /s/ Gregg Stanley - ------------------------------------------- Gregg Stanley /s/ Anthony Taparo - ------------------------------------------- Anthony Taparo 6 ARC KEY SHAREHOLDERS: ARTHUR S. DEMOSS FOUNDATION By: --------------------------------------- Name: -------------------------------------- Title: ------------------------------------ /s/ Jerry M. Eyler - ------------------------------------------- Jerry M. Eyler FIRST AVENUE PARTNERS, L.P. /s/ Front Street, LLC, General Partner - -------------------------------------- Name: David M. Wilds -------------------------------------- Title: Managing Member ------------------------------------ - ------------------------------------------- William H. Freeman - ------------------------------------------- J. Michael Gould HEALTH TECH AFFILIATES, INC. By: --------------------------------------- Name: -------------------------------------- Title: ------------------------------------ HLM/CB FUND, L.P. - ------------------------------------------- By: --------------------------------------- Name: -------------------------------------- Title: ------------------------------------ 7 HLM PARTNERS VII, L.P. - ------------------------------------------- By: --------------------------------------- Name: -------------------------------------- Title: ------------------------------------ - ------------------------------------------- W. Lawrence Hough PIPER JAFFRAY, INC. By: --------------------------------------- Name: -------------------------------------- Title: ------------------------------------ - ------------------------------------------- B. Max Lauderdale /s/ Charles N. Martin, Jr. - ------------------------------------------- Charles N. Martin, Jr. /s/ Charles T. Neal - ------------------------------------------- Charles T. Neal - ------------------------------------------- Richard Panek - ------------------------------------------- Thomas Patten - ------------------------------------------- Keith B. Pitts - ------------------------------------------- Gary J. Prosterman 8 RICHLAND VENTURES II, L.P. By: /s/ Jack Tyrrell --------------------------------------- Name: Jack Tyrrell -------------------------------------- Title: Partner ------------------------------------ - ------------------------------------------- Ann R. Schaaf SOUTH ATLANTIC PRIVATE EQUITY FUND IV (QP), LIMITED PARTNERSHIP By: South Atlantic Private Equity Partners IV, Limited Partnership, its general partner By: /s/ Donald W. Burton --------------------------------------- Name: Donald W. Burton -------------------------------------- Title: Chairman ------------------------------------- South Atlantic Private Equity Fund IV, L.P. By: South Atlantic Private Equity Partners IV, Limited Partnership, its general partner By: /s/ Donald W. Burton --------------------------------------- Name: Donald W. Burton -------------------------------------- Title: Chairman ------------------------------------- - --------------------------------------------------------- Cal Turner, Jr. /s/ William V.B. Webb - --------------------------------------------------------- William V.B. Webb WW TWO, L.P. - --------------------------------------------------------- By: ----------------------------------------------------- Name: ---------------------------------------------------- Title: -------------------------------------------------- 9 - ----------------------------------------------------- James A. Webb, III UNIPHY FOUNDERS: - ----------------------------------------------------- Peter Davidson - ----------------------------------------------------- Shannon W. Fiser THE FRANCIS IRREVOCABLE TRUST, ANN FRANCIS, TRUSTEE /s/ Richard E. Francis, Jr. - ----------------------------------------------------- Name: Richard E. Francis, Jr. ----------------------------------------------- Title: ---------------------------------------------- - ----------------------------------------------------- Victor Giovanetti /s/ George M. Goodwin - ----------------------------------------------------- George M. Goodwin - ----------------------------------------------------- Marlene D. Kelley /s/ H. Edward Kleine III - ----------------------------------------------------- H. Edward Kleine III - ----------------------------------------------------- Darrell Naish - ----------------------------------------------------- Richard Panek /s/ Vickie R. Warren - ----------------------------------------------------- Vickie R. Warren 10 EXHIBIT A SCHEDULE OF INVESTORS UNIPHY PREFERRED SHAREHOLDERS ABS Capital Partners, L.P.* Clifford G. Adlerz* Randy W. Cook* Paul Davis* Richard E. Francis, Jr.* R. Dale Kennedy* Tod Lambert Martin Investment Partnership II* Kenneth C. Mitchell* Pacific Venture Group, L.P.* PVG Associates, L.P.* Patrick R. Rooney* Teresa F. Sparks* Gregg Stanley* Anthony Taparo* ARC KEY SHAREHOLDERS Arthur S. Demoss Foundation* Jerry M. Eyler* First Avenue Partners, L.P.* William H. Freeman J. Michael Gould Health Tech Affiliates, Inc. HLM/CB Fund, L.P.* HLM Partners VII, L.P.* W. Lawrence Hough Piper Jaffray, Inc.* B. Max Lauderdale Charles N. Martin, Jr.* Charles T. Neal* Thomas Patten Keith B. Pitts Gary J. Prosterman Richland Ventures II, L.P.* Ann R. Schaaf South Atlantic Private Equity Fund IV (QP)* South Atlantic Private Equity Fund IV, L.P.* Cal Turner, Jr.* William V.B. Webb* WW Two, L.P.* James A. Webb, III * ANTI-DILUTION INVESTOR UNIPHY FOUNDERS Peter Davidson Shannon W. Fiser The Francis Irrevocable Trust, Ann Francis, Trustee* Victor Giovanetti George M. Goodwin Marlene D. Kelley H. Edward Kleine III Darrell Naish Richard Panek Vickie R. Warren * ANTI-DILUTION INVESTOR 2